Peer-Reviewed Article Validates Tack Endovascular System® as a Clinically Important Treatment for Post-Angioplasty Dissection Repair in Above-the-Knee Complex Lesions WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the peer-reviewed publication of its Tack Optimized Balloon Angioplasty (TOBA) III 12-month clinical trial results in the Journal of Vascular […]
Other News
Ostial Corporation Reaches 15,000 FLASH™ System Units Sold
Novel dual-balloon technology designed for true 360° stent apposition CAMPBELL, Calif., May 12, 2020 /PRNewswire/ — Ostial Corporation (Ostial), a private medical technology company focused on addressing the clinical challenges of aorto-ostial interventions, today reached a new milestone, passing the mark of 15,000 commercial units sold of its FLASH™ Aorto-Ostial Angioplasty System (FLASH System) in […]
Affera’s Technology for Cardiac Arrhythmia Treatment Highlighted at the 2020 Heart Rhythm Society Late-Breaking Clinical Trial Session and Three Simultaneous Publications
WATERTOWN, Mass., May 12, 2020 /PRNewswire/ — Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today that its platform was featured prominently in scientific sessions at the Heart Rhythm Society 2020 (HRS) meeting held online May 6-9. Simultaneously, three manuscripts describing pre-clinical experiments and clinical trials […]
Daniel R. Goldstein, MD, Named Incoming Editor-in-Chief of the Journal of Heart and Lung Transplantation
ADDISON, Texas, May 12, 2020 (GLOBE NEWSWIRE) — The International Society for Heart and Transplantation, which publishes the Journal of Heart and Lung Transplantation, named Daniel R. Goldstein, MD, the new editor-in-chief of the Journal. Dr. Goldstein is the Eliza Maria Mosher Collegiate Professor in Internal Medicine and Director of the […]
Shockwave Medical Reports First Quarter 2020 Financial Results
SANTA CLARA, Calif., May 12, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended March 31, 2020. Recent Highlights Recognized revenue of $15.2 million […]
Cereno Scientific Expands Footprint Into the United States With a Subsidiary in Boston, MA
STOCKHOLM, May 13, 2020 /PRNewswire/ — Cereno Scientific today announced that the company has expanded its global footprint by establishing a subsidiary with new office space located in Kendall Square at the Cambridge Innovation Center (CIC), Cambridge, Boston, Massachusetts. The CIC is one of the industry’s most recognized biotechnology hubs and has supported more than […]
Medicure Reports Financial Results for Quarter Ended March 31, 2020
WINNIPEG, May 12, 2020 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today reported its results from operations for the quarter ended March 31, 2020. Quarter Ended March 31, 2020 Highlights: Recorded total net revenue from the sale of products of $3.0 million during the quarter ended March 31, 2020 compared to $4.9 million for […]
Philips receives FDA clearance for the use of its ultrasound portfolio to manage COVID-19-related lung and cardiac complications
May 13, 2020 Philips’ ultrasound portfolio, including Lumify with Reacts handheld tele-ultrasound solution, provides valuable diagnostic insight for front-line care providers Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration […]
CARMAT Obtains Approval for the Reimbursement of Its Total Artificial Heart During the US Clinical Feasibility Study
Centers for Medicare & Medicaid Services (CMS) confirms coverage of the device and routine care items and services PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart […]
PhaseBio Reports First Quarter 2020 Financial Results and Recent Business Highlights
Initiated PB2452 Phase 3 Trial for the Reversal of the Antiplatelet Effects of Ticagrelor MALVERN, Pa & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today reported financial results from the first quarter ending March 31, […]



